[1] Zhang, B. et al.
Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19. medRxiv 2020.03.12.20035048 (2020). doi:10.1101/2020.03.12.2003504
[2] Geretti AM, Stockdale AJ, Kelly SH, Cevik M, Collins S, Waters L, Villa G, Docherty A, Harrison EM, Turtle L, Openshaw PJM, Baillie JK, Sabin CA, Semple MG. Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study. Clin Infect Dis. 2020 Oct 23:ciaa1605. doi: 10.1093/cid/ciaa1605.
[3] Widjaja G, Turki Jalil A, Sulaiman Rahman H, Kamal Abdelbasset W, Bokov DO, Suksatan W, Ghaebi M, Marofi F, Gholizadeh Navashenaq J, Jadidi-Niaragh F, Ahmadi M. Humoral immune mechanisms involved in protective and pathological immunity during COVID-19. Hum Immunol. 2021 Jul 1:S0198-8859(21)00174-9. doi: 10.1016/j.humimm.2021.06.011.
[4] Zhong, L., Coe, S.P., Stromberg, A.J., Khattar, N.H., Jett, J.R. and Hirschowitz, E.A. (2006)
Profiling Tumor-Associated Antibodies for Early Detection of Non-Small Cell Lung Cancer. Journal of Thoracic Oncology, 1, 513-519. https://doi.org/10.1016/S1556-0864(15)30352-X
[5] Chu GWC, Lazare K, Sullivan FM. Serum and blood based biomarkers for lung cancer screening: a systematic review. BMC Cancer 2018) 18:181 DOI 10.1186/s12885-018-4024-3
[6] Anderson, K.S. and LaBaer, J. (2005) The Sentinel Within: Exploiting the Immune System for Cancer Biomarkers. Journal of Proteome Research, 4, 1123-1133. https://doi.org/10.1021/pr0500814
[7] Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JF. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila). 2011 Jul;4(7):1126-34. doi: 10.1158/1940-6207.CAPR-10-0328.
[8] Murray A, Chapman CJ, Healey G, Peek LJ, Parsons G, Baldwin D, Barnes A, Sewell HF, Fritsche HA, Robertson JFR. Technical validation of an autoantibody test for lung cancer. Ann Oncol. 2010 Aug;21(8):1687-1693. doi: 10.1093/annonc/mdp606. Epub 2010 Feb 2
[9] Murray, A., Chapman, C.J., Healey, G., Peek, L.J., Parsons, G., Baldwin, D., Barnes, A., Sewell, H.F., Fritsche, H.A. and Robertson, J.F. (2010) Technical Validation of an Autoantibody Test For Lung Cancer. Annals of Oncology, 21, 1687-1693. https://doi.org/10.1093/annonc/mdp606
[10] Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of Biomarker Development for Early Detection of Cancer. JNCI J. Natl. Cancer Institute. Oxford University Press; 2001 []; 93: 1054–106 doi/10.1093/jnci/93.14.1054.
[11] Sullivan FM, Mair FS, Anderson W, Armory P, Briggs A, Chew C, Dorward A, Haughney J, Hogarth F, Kendrick D, Littleford R, McConnachie A, McCowan C, Mcmeekin N, Patel M, Rauchhaus P, Ritchie L, Robertson C, Robertson J, Robles-Zurita J, Sarvesvaran J, Sewell H, Sproule M, Taylor T, Tello A, Treweek S, Vedhara K, Schembri S; Early Diagnosis of Lung Cancer Scotland (ECLS) Team. Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging. Eur Respir J. 2020 Jul 30:2000670. doi: 10.1183/13993003.00670-2020.
[12] Sullivan F, Farmer E, Mair FS, Treweek S, Kendrick D, Jackson C, Robertson C, Briggs A, McCowan C, Bedford L, Young B, Vedhara K, Gallant S, Littleford R, Robertson J, Sewell H, Dorward A, Sarvesvaran J, Schembri S. Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial. BMC Cancer (2017) 17:187 DOI 10.1186/s12885-017-3175-y
[13] Kendrick S, Clarke J. The Scottish record linkage system.HealthBulletin (Edinburgh)1993;51:72–9.
[14] Mulholland RH, Vasileiou E, Simpson CR, Robertson C, Ritchie LD, Agrawal U, Woolhouse M, Murray JLK, Stagg HR, Docherty AB, McCowan C, Wood R, Stock SJ, Sheikh A. Cohort profile:
Early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database. Int J Epidemiol. 2021 Apr 16:dyab028. doi: 10.1093/ije/dyab028.
[15] National Health Service (NHS). Community Health Index (CHI). Available online: https://datadictionary.nhs.uk/attributes/community_health_index_number.html (last accessed 12.8.21)
[16] Data Linkage Service University of Dundee https://www.dundee.ac.uk/hic/datalinkageservice/ last accessed 12.8.21
[17] Qi X, Liu C, Jiang Z, Gu Y, Zhang G, Shao C, Yue H, Chen Z, Ma B, Liu D, Zhang L, Wang J, Xu D, Lei J, Li X, Huang H, Wang Y, Liu H, Yang J, Pan H, Liu W, Wang W, Li F, Zou S, Zhang H, Dong J. Multicenter analysis of clinical characteristics and outcomes in patients with COVID-19 who develop liver injury. J Hepatol. 2020 Aug;73(2):455-458. doi: 10.1016/j.jhep.2020.04.010.
[18] Shen B, Yi X, Sun Y, et al.
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.
Cell. 2020;182(1):59-72. e15.